Data / Form D filings / Acton Pharmaceuticals, Inc.
Acton Pharmaceuticals, Inc.: Form D filings
Acton Pharmaceuticals, Inc., a pharmaceuticals company in Marlborough, MA, filed 3 Form D notices with the SEC between 2009 and 2013. The latest, on May 20, 2013, reports $7 million sold of a $7 million offering to 2 investors.
Find out what Acton Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 225 CEDAR HILL STREET, SUITE 115, Marlborough, MA, 01752
- Phone
- (508) 624-8733
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1478610
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 20, 2013 | New notice | $7,000,005 | $7,000,005 | $0 | 2 | May 13, 2013 | sec.gov |
| Sep 30, 2010 | New notice | $14,199,512 | $14,199,512 | $0 | 2 | Sep 29, 2010 | sec.gov |
| Dec 15, 2009 | New notice | $10,000,003 | $500,000 | $9,500,003 | 1 | Dec 10, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott Carter | Director | |
| Daniel Kreisler | Executive Officer, Director, Promoter | |
| Thomas Phair | Executive Officer | |
| John Simon | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of May 20, 2013 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Acton Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.